Arcellx announces strategic collaboration with Kite, a Gilead Company, to co-develop and co- commercialize late- stage clinical CART-ddBCMA in multiple myeloma Notable Dec 9 Written By Frances Benson https://ir.arcellx.com/news/news-details/2022/Arcellx-and-Kite-Announce-Strategic-Collaboration-to-Co-Develop-and-Co-Commercialize-Late-Stage-Clinical-CART-ddBCMA-in-Multiple-Myeloma/default.aspx 2022 Frances Benson
Arcellx announces strategic collaboration with Kite, a Gilead Company, to co-develop and co- commercialize late- stage clinical CART-ddBCMA in multiple myeloma Notable Dec 9 Written By Frances Benson https://ir.arcellx.com/news/news-details/2022/Arcellx-and-Kite-Announce-Strategic-Collaboration-to-Co-Develop-and-Co-Commercialize-Late-Stage-Clinical-CART-ddBCMA-in-Multiple-Myeloma/default.aspx 2022 Frances Benson
